SEARCH

SEARCH BY CITATION

References

  • 1
    Shannon CS, Winikoff B, Hausknecht R, Schaff E, Blumenthal PD, Oyer D, et al. Multicenter trial of a simplified mifepristone medial abortion regimen. Obstet Gynecol 2005;105:34551.
  • 2
    Alan Guttmacher Institute. Women, Families and the Future. New York, NY: AGI, 1994.
  • 3
    World Health Organization. Maternal Health and Safe Motherhood Programme. Abortion: A Tabulation of Available Data on the Frequency and Mortality of Unsafe Abortion, 2nd edn. Geneva, Switzerland: WHO, 1994.
  • 4
    Carbonell JL, Varela L, Velazco A, Fernandez C. The use of misoprostol for termination of early pregnancy. Contraception 1997;55:1658.
  • 5
    Jain JK, Dutton C, Harwood B, Meckstroth K, Mishell DR. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy. Hum Reprod 2002;17:147782.
  • 6
    Carbonell JL, Rodriguez J, Velazco A, Tanda R, Sanchez C, Barambio S, et al. Oral and vaginal misoprostol 800 microg every 8 h for early abortion. Contraception 2003;67:45762.
  • 7
    Creinin MD, Vittinghoff E. Methotrexate and misoprostol vs. misoprostol alone for early abortion. JAMA 1994;272:11905.
  • 8
    Carbonell JL, Varela L, Velazco A, Fernandez C, Sanchez C. The use of misoprostol for abortion at ≤ 9 weeks’ gestation. Eur J Contracept Reprod Health Care 1997;2:1815.
  • 9
    Jain JK, Mekstroth KR, Park M, Mishell DR Jr. Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol. Am J Obstet Gynecol 1999;181:138691.
  • 10
    Blanchard K, Shochet T, Coyaji K, Thi Nhu Ngoc N, Winikoff B. Misoprostol alone for early abortion: an evaluation of seven potential regimens. Contraception 2005;72:917.
  • 11
    Consensus Statement: Instructions for Use-Abortion Induction with Misoprostol in Pregnancies up to 9 Weeks LMP. Expert Meeting on Misoprostol sponsored by Reproductive Health Technologies Project and Gynuity Health Projects. New York: Gynuity Health Projects, 2003.
  • 12
    Creinin MD, Vittinghoff E, Schaff E, Klaisle C, Darney PD, Dean C. Medical abortion with oral methotrexate and vaginal misoprostol. Obstet Gynecol 1997;90:6116.
  • 13
    Creinin MD. Medical abortion with methotrexate 75 mg intramuscularly and vaginal misoprostol. Contraception 1997;56:36771.
  • 14
    Hausknecht RU. Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med 1995;333:53740.
  • 15
    Schaff EA, Eisinger SH, Franks P, Kim SS. Combined methotrexate and misoprostol for early induced abortion. Arch Fam Med 1995;4:7749.
  • 16
    Wiebe ER. Oral methotrexate compared with injected methotrexate when used with misoprostol for abortion. Am J Obstet Gynecol 1999;181:14952.
  • 17
    Carbonell JL, Varela L, Velazco A, Cabezas E, Fernandez C, Sanchez C. Oral methotrexate and vaginal misoprostol for early abortion. Contraception 1998;57:838.
  • 18
    Creinin MD. Oral methotrexate and vaginal misoprostol for early abortion. Contraception 1996;54:1518.
  • 19
    Borgotta L, Burnhill M, Haskell S, Nichols M, Leonhardt K. Instituting medical abortion services: changes in outcome and acceptability related to provider experience. J Am Med Womens Assoc 2000;55(3 Suppl):1736.
  • 20
    Bartley J, Tong S, Everington D, Baird D. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 2000;62:297303.
  • 21
    Spitz IM, Bardin WC, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338:12417.
  • 22
    Agostini A, Ronda I, Capelle M, Romain F, Bretelle F, Blanc B. Influence of clinical and ultrasound factors on the efficacy of misoprostol in first trimester pregnancy failure. Fertil Steril 2005;84:10302.
  • 23
    Wiebe ER, Trouton K. Comparing vaginal and buccal misoprostol when used after methotrexate for early abortion. Contraception 2004;70:4636.
  • 24
    Middleton T, Schaff E, Fielding SL, Scahill M, Shannon C, Westheimer E, et al. Randomized trial of mifepristone and vaginal or buccal misoprostol for abortion through 56 days of last menstrual period. Contraception 2005;72:32832.
  • 1c
    Royal College of Obstetricians and Gynaecologists. Induced Abortion. RCOG Guideline 11, London: Royal College of Obstetricians and Gynaecologists; 1997.
  • 2c
    Creinin MD, Vittinghoff E, Schaff E, Klaisle C, Darney PD, Dean C. Medical abortion with oral methotrexate and vaginal misoprostol. Obstet Gynecol 1997;90:61116.
  • 3c
    Schaff EA, Eisinger SH, Franks P, Kim SS. Combined methotrexate and misoprostol for early induced abortion. Arch Fam Med 1995;4:7749.
  • 4c
    Carbonell JL, Varela L, Velazco A, Cabezas E, Fernandez C, Sanchez C. Oral methotrexate and vaginal misoprostol for early abortion. Contraception 1998;57:838.